FLG enters October earnings season with a quiet but persistent build in bearish positioning — short interest has crept higher for weeks, options traders are more defensive than usual, and the stock has shed 8% in the past month.
Short sellers have been methodically adding pressure. SI as a percentage of free float now runs at 8.3%, up almost 5% over the past month as measured by share count, with the daily estimate climbing to just over 34.5 million shares. That is not an extreme level on its own, but the direction is unambiguous — shorts have been rebuilding steadily since mid-August after trimming back in early August. The borrow cost remains cheap at 0.59%, up roughly 40% on the week but still firmly in "easy to borrow" territory. Availability is generous at around 522%, meaning there are more than five shares available to lend for every one already borrowed. This rules out any near-term squeeze dynamic. The lending market tells a story of orderly short accumulation rather than forced positioning.
Options have turned more defensive in recent days. The put/call ratio is running at 0.75, about 1.3 standard deviations above its 20-day average of 0.64 — the highest it has been since the peak reading of 1.00 over the past year. That shift is almost entirely a function of the last two weeks: the PCR was cycling between 0.56 and 0.61 through early August, then jumped sharply around August 21 and has held near 0.75 since. The options market is not panicking, but it is hedging at a materially higher rate than it was a fortnight ago. Combined with the short interest rebuild, the positioning picture looks cautiously bearish rather than aggressively so.
The Street retains a broadly positive bias, though with diminished conviction after the July earnings miss. Most brokers hold Buy or Overweight ratings, with targets clustered in the $15–$18 range against a current price of $13.06. Raymond James freshly assumed coverage this week at Market Perform, a notably cooler entry point compared to the UBS and TD Cowen initiations in early July that came in at Buy with $18 targets. RBC trimmed its target to $15 after the Q2 print, putting the price-to-book at around 0.69x — a discount to book that the bulls read as opportunity and the bears read as a reflection of ongoing credit quality concerns. The ORTEX short score of 61.2 places FLG in moderately elevated short-pressure territory; it has been stuck in a narrow band between 60 and 62 for the past two weeks, suggesting neither shorts nor longs have conviction enough to break the range.
The ownership structure is worth flagging. Liberty 77 Capital filed a Schedule 13D/A last October, disclosing a stake that then stood at 24.9% — the single largest institutional holder and an activist on the register. BlackRock reported just over 10% as of end-July and added roughly 1.9 million shares in the most recent period. Both Vanguard entities combined hold another 6.8%, though one Vanguard vehicle trimmed meaningfully earlier this year. Hudson Bay Capital has been cutting sharply, filing a 13G/A in August that showed its stake had fallen from 8.4% to 2.3% — a reduction of roughly 25 million shares. That is a material exit from a significant holder, and it is worth noting the disclosure caveat: 13D/G positions are event-driven around the 5% threshold, so actual current stakes may differ from the last filing. (Schedule 13D/G stakes are as last disclosed; holders falling below 5% may not file again.)
Earnings history gives the bears more ammunition than the bulls. The July 24 Q2 report triggered a 6.5% single-day drop, with losses extending to around 3.3% over the subsequent five days. Next quarter's release is scheduled for October 23. Between now and then, the metric to watch is whether the short interest build accelerates or stabilises — if availability tightens meaningfully from its current loose reading while the PCR holds elevated, the positioning setup heading into October would look considerably more charged than it does today.
See the live data behind this article on ORTEX.
Open FLG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
